ArriVent BioPharma Statistics
Total Valuation
AVBP has a market cap or net worth of $1.46 billion. The enterprise value is $1.14 billion.
| Market Cap | 1.46B |
| Enterprise Value | 1.14B |
Important Dates
The next estimated earnings date is Wednesday, August 19, 2026, before market open.
| Earnings Date | Aug 19, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AVBP has 46.57 million shares outstanding. The number of shares has increased by 22.48% in one year.
| Current Share Class | 46.57M |
| Shares Outstanding | 46.57M |
| Shares Change (YoY) | +22.48% |
| Shares Change (QoQ) | +4.95% |
| Owned by Insiders (%) | 1.93% |
| Owned by Institutions (%) | 68.81% |
| Float | 29.59M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 218.30 |
| PB Ratio | 4.39 |
| P/TBV Ratio | 4.51 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.95, with a Debt / Equity ratio of 0.00.
| Current Ratio | 13.95 |
| Quick Ratio | 13.06 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -55.17% and return on invested capital (ROIC) is -37.20%.
| Return on Equity (ROE) | -55.17% |
| Return on Assets (ROA) | -34.72% |
| Return on Invested Capital (ROIC) | -37.20% |
| Return on Capital Employed (ROCE) | -48.37% |
| Weighted Average Cost of Capital (WACC) | 11.76% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.89M |
| Employee Count | 77 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +74.49% in the last 52 weeks. The beta is 1.37, so AVBP's price volatility has been higher than the market average.
| Beta (5Y) | 1.37 |
| 52-Week Price Change | +74.49% |
| 50-Day Moving Average | 31.71 |
| 200-Day Moving Average | 25.71 |
| Relative Strength Index (RSI) | 51.30 |
| Average Volume (20 Days) | 496,489 |
Short Selling Information
The latest short interest is 7.67 million, so 16.46% of the outstanding shares have been sold short.
| Short Interest | 7.67M |
| Short Previous Month | 7.62M |
| Short % of Shares Out | 16.46% |
| Short % of Float | 25.90% |
| Short Ratio (days to cover) | 12.18 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -156.87M |
| Pretax Income | -145.24M |
| Net Income | -145.24M |
| EBITDA | -156.87M |
| EBIT | -156.87M |
| Earnings Per Share (EPS) | -$3.52 |
Balance Sheet
The company has $326.38 million in cash and $419,000 in debt, with a net cash position of $325.96 million or $7.00 per share.
| Cash & Cash Equivalents | 326.38M |
| Total Debt | 419,000 |
| Net Cash | 325.96M |
| Net Cash Per Share | $7.00 |
| Equity (Book Value) | 323.98M |
| Book Value Per Share | 7.15 |
| Working Capital | 323.71M |
Cash Flow
| Operating Cash Flow | -134.47M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | -134.47M |
| FCF Per Share | -$2.89 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AVBP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -22.48% |
| Shareholder Yield | -22.48% |
| Earnings Yield | -9.93% |
| FCF Yield | -9.20% |
Analyst Forecast
The average price target for AVBP is $44.60, which is 42.08% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $44.60 |
| Price Target Difference | 42.08% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |